| Year |
Citation |
Score |
| 2015 |
Thornton JA, Tullos NA, Sanders ME, Ridout G, Wang YD, Taylor SD, McDaniel LS, Marquart ME. Differential bacterial gene expression during experimental pneumococcal endophthalmitis. Ophthalmic Research. 53: 149-61. PMID 25791614 DOI: 10.1159/000371713 |
0.599 |
|
| 2013 |
Tullos NA, Thompson HW, Taylor SD, Sanders M, Norcross EW, Tolo I, Moore Q, Marquart ME. Modulation of immune signaling, bacterial clearance, and corneal integrity by toll-like receptors during streptococcus pneumoniae keratitis. Current Eye Research. 38: 1036-48. PMID 23841825 DOI: 10.3109/02713683.2013.804094 |
0.773 |
|
| 2013 |
Taylor SD, Sanders ME, Tullos NA, Stray SJ, Norcross EW, McDaniel LS, Marquart ME. The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells. Plos One. 8: e61300. PMID 23577214 DOI: 10.1371/Journal.Pone.0061300 |
0.749 |
|
| 2013 |
Sanders ME, Taylor S, Tullos N, Norcross EW, Moore QC, Thompson H, King LB, Marquart ME. Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis. Bmc Ophthalmology. 13: 8. PMID 23496928 DOI: 10.1186/1471-2415-13-8 |
0.789 |
|
| 2011 |
Norcross EW, Sanders ME, Moore QC, Marquart ME. Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells. Journal of Bacteriology & Parasitology. 2: 108. PMID 22229113 DOI: 10.4172/2155-9597.1000108 |
0.771 |
|
| 2011 |
Norcross EW, Sanders ME, Moore QC, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis. Investigative Ophthalmology & Visual Science. 52: 9232-43. PMID 22039231 DOI: 10.1167/Iovs.10-6968 |
0.781 |
|
| 2011 |
Sanders ME, Norcross EW, Robertson ZM, Moore QC, Fratkin J, Marquart ME. The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Investigative Ophthalmology & Visual Science. 52: 865-72. PMID 21051708 DOI: 10.1167/Iovs.10-5513 |
0.789 |
|
| 2011 |
Sanders ME, Moore QC, Norcross EW, Sanfilippo CM, Hesje CK, Shafiee A, Marquart ME. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Cornea. 30: 83-90. PMID 20847656 DOI: 10.1097/Ico.0B013E3181E2F0F3 |
0.769 |
|
| 2010 |
Sanders ME, Tullos NA, Taylor SD, Norcross EW, King LB, Tolo I, Marquart ME. Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. Current Eye Research. 35: 1142-7. PMID 21121810 DOI: 10.3109/02713683.2010.512114 |
0.736 |
|
| 2010 |
Sanders ME, Norcross EW, Moore QC, Fratkin J, Thompson H, Marquart ME. Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 26: 571-7. PMID 21034245 DOI: 10.1089/Jop.2010.0077 |
0.773 |
|
| 2010 |
Norcross EW, Tullos NA, Taylor SD, Sanders ME, Marquart ME. Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection. Current Eye Research. 35: 787-98. PMID 20795860 DOI: 10.3109/02713683.2010.492462 |
0.768 |
|
| 2010 |
Norcross EW, Sanders ME, Moore Q, Sanfilippo CM, Hesje CK, Shafiee A, Marquart ME. Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 26: 237-43. PMID 20565309 DOI: 10.1089/Jop.2009.0154 |
0.768 |
|
| 2010 |
Sanders ME, Moore QC, Norcross EW, Shafiee A, Marquart ME. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 26: 193-8. PMID 20334537 DOI: 10.1089/Jop.2009.0121 |
0.766 |
|
| 2009 |
Sanders ME, Norcross EW, Moore QC, Shafiee A, Marquart ME. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea. 28: 1055-60. PMID 19724203 DOI: 10.1097/Ico.0B013E31819E34Cb |
0.768 |
|
| 2009 |
Moore QC, McCormick CC, Norcross EW, Onwubiko C, Sanders ME, Fratkin J, McDaniel LS, O'Callaghan RJ, Marquart ME. Development of a Streptococcus pneumoniae keratitis model in mice. Ophthalmic Research. 42: 141-6. PMID 19628954 DOI: 10.1159/000229028 |
0.769 |
|
| 2008 |
Sanders ME, Norcross EW, Moore QC, Onwubiko C, King LB, Fratkin J, Marquart ME. A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model. Clinical Ophthalmology (Auckland, N.Z.). 2: 793-800. PMID 19668433 DOI: 10.2147/Opth.S3941 |
0.767 |
|
| 2008 |
Green SN, Sanders M, Moore QC, Norcross EW, Monds KS, Caballero AR, McDaniel LS, Robinson SA, Onwubiko C, O'Callaghan RJ, Marquart ME. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Investigative Ophthalmology & Visual Science. 49: 290-4. PMID 18172105 DOI: 10.1167/Iovs.07-0492 |
0.772 |
|
| 2007 |
Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ. Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. Investigative Ophthalmology & Visual Science. 48: 2661-6. PMID 17525197 DOI: 10.1167/Iovs.07-0017 |
0.625 |
|
| Show low-probability matches. |